Metformin in pregnancy: Its time has not yet come [36]

Diabetes Care

Volumn 29, Issue 2, 2006, Pages 485-486

  Brown, Florence M ^a   Wyckoff, Jennifer ^a   Rowan, Janet A ^b   Jovanovic, Lois ^c   Sacks, David A ^d   Briggs, Gerald G ^e  

^a JOSLIN DIABETES CENTER   (United States)

^b NATIONAL WOMEN S HOSPITAL   (New Zealand)

^c SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^d KAISER FOUNDATION HOSPITAL   (United States)

^e LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; ANTIDIABETIC AGENT;

BIRTH WEIGHT; DIABETES MELLITUS; DIARRHEA; DRUG SAFETY; FETUS GROWTH; HUMAN; INSULIN RESISTANCE; INSULIN TREATMENT; LACTIC ACIDOSIS; LETTER; MATERNAL WELFARE; NAUSEA; NEWBORN CARE; OBESITY; OVARY POLYCYSTIC DISEASE; PREGNANCY; PREGNANCY DIABETES MELLITUS; RISK ASSESSMENT; TERATOGENICITY; CONFERENCE PAPER; DIET THERAPY; FEMALE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME;

DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME;

EID: 33646366433     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.1353/aq.2006.0036     Document Type: Letter

References (6)

1. American Diabetes Association: Metformin shown to be safe and effective in pregnancy. Bayside Tribune, 12 June 2005: p. 1 (newsletter from 65th Annual Scientific Sessions, San Diego, CA, 10-14 June 2005)
2. Bailey CJ, Turner RC. Metformin. N Engl J Med 334:574-579, 1996
3. Glueck CJ, Goldenberg N, Wang P, Loftspring M, Sherman A: Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone, and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod 19:510-521, 2004
4. Glueck CJ, Goldenberg N, Pranikoff J, Loftspring M, Sieve L, Wang P: Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 19:1323-1330, 2004
5. Hague WM, Davoren PM, McIntyre HD, Norris R, Xiaonian X, Charles B: Metformin crosses the placenta: a modulator for fetal insulin resisitance? [article online], 4 December 2003. Available from http://bmj.bmjjournals.com/ cgi/eletters/327/7420/880. Accessed 1 July 2005 (BMJ Rapid Response letter)
6. Vanky E, Zahlsen K, Spigset O, Carlsen SM: Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steriil 83:1575-1578, 2005